Pathophysiology of zonular diseases

Current Opinion in Ophthalmology

Volumn 19, Issue 1, 2008, Pages 27-30

  Dureau, Pascal ^a  

^a FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

Author keywords

Ectopia lentis; Glaucoma; Marfan syndrome; Zonule

Indexed keywords

FIBRILLIN;

CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; DISEASE COURSE; ECTOPIA LENTIS; GENETIC COUNSELING; HERITABILITY; HISTOLOGY; HUMAN; LENS IMPLANT; MARFAN SYNDROME; MYOPIA; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFRACTION ERROR; RETINA DETACHMENT; REVIEW; SURGICAL TECHNIQUE; WEILL MARCHESANI SYNDROME;

ECTOPIA LENTIS; FIBRIN; GLAUCOMA; HUMANS; MARFAN SYNDROME; REFRACTION, OCULAR; REFRACTIVE ERRORS;

EID: 37349016857     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282f29f01     Document Type: Review

References (40)

1. Le Parc JM, Molcard S, Tubach F, et al. Marfan syndrome and fibrillin disorders. Joint Bone Spine 2000; 67:401-407.
2. Van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001; 84:129-137.
3. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62:417-426.
4. Nemet AY, Assia EI, Apple DJ, Barequet IS. Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol 2006; 51:561-575. A complete and structured review of molecular, genetic, clinical and therapeutic aspects of ocular manifestations in MFS and related fibrillinopathies.
5. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986; 103:2499-2509.
6. Ashworth JL, Kielty CM, McLeod D. Fibrillin and the eye. Br J Ophthalmol 2000; 84:1312-1317.
7. Kielty CM, Sherratt MJ, Marson A, Baldock C. Fibrillin microfibrils. Adv Protein Chem 2005; 70:405-436.
8. Wheatley HM, Traboulsi EI, Flowers BE, et al. Immunohistochemical localization of fibrillin in human ocular tissues: relevance to the Marfan syndrome. Arch Ophthalmol 1995; 113:103-109.
9. Hanssen E, Franc S, Garrone R. Synthesis and structural organization of zonular fibers during development and aging. Matrix Biol 2001; 20:77-85.
10. Reinhardt DP, Ono RN, Notbohm H, et al. Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis: a potential disease-causing mechanism in Marfan syndrome. J Biol Chem 2000; 275:12339-12345.
11. Booms P, Pregla R, Ney A, et al. RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome. Hum Genet 2005; 116:51-61.
12. Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 2000; 37:9-25.
13. Biggin A, Holman K, Brett M, et al. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy. Hum Mutat 2004; 23:99.
14. Ganesh A, Smith C, Chan W, et al. Immunohistochemical evaluation of conjunctival fibrillin-1 in Marfan syndrome. Arch Ophthalmol 2006; 124: 205-209.
15. Boileau C, Jondeau G, Mizuguchi T, Matsumoto N. Molecular genetics of Marfan syndrome. Curr Opin Cardiol 2005; 20:194-200.
16. Rommel K, Karck M, Haverich A, et al. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat 2005; 26:529-539.
17. Robinson PN, Booms P, Katzke S, et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 2002; 20:153-161.
18. Mir S, Wheatley HM, Hussels IE, et al. A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Invest Ophthalmol Vis Sci 1998; 39:84-93.
19. Traboulsi EI, Whittum-Hudson JA, Mir SH, Maumenee IH. Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis. Ophthalmic Genet 2000; 21:9-15.
20. Dagi LR, Walton DS. Anterior axial lens subluxation, progressive myopia, and angle-closure glaucoma: recognition and treatment of atypical presentation of ectopia lentis. J AAPOS 2006; 10:345-350. Case series illustrating the mechanisms of myopia and glaucoma in ectopia lentis.
21. Izquierdo NJ, Traboulsi EI, Enger C, Maumenee IH. Glaucoma in the Marfan syndrome. Trans Am Ophthalmol Soc 1992; 90:111-117; discussion 118-122.
22. Krupin T. Marfan syndrome, lens subluxation, and open-angle glaucoma. J Glaucoma 1999; 8:396-399.
23. Ritch R, Chang BM, Liebmann JM. Angle closure in younger patients. Ophthalmology 2003; 110:1880-1889.
24. Barkana Y, Shihadeh W, Oliveira C, et al. Angle closure in highly myopic eyes. Ophthalmology 2006; 113:247-254.
25. Madill SA, Bain KE, Patton N, et al. Emergency use of pilocarpine and pupil block glaucoma in ectopia lentis. Eye 2005; 19:105-107.
26. Doyle A, Hamard P, Puech M, Lachkar Y. Asymmetric pigmentary glaucoma in a patient with Marfan's syndrome. Graefes Arch Clin Exp Ophthalmol 2005; 243:955-957.
27. Sultan G, Baudouin C, Auzerie O, et al. Cornea in Marfan disease: Orbscan and in vivo confocal microscopy analysis. Invest Ophthalmol Vis Sci 2002; 43:1757-1764.
28. Dagoneau N, Benoist-Lasselin C, Huber C, et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am J Hum Genet 2004; 75:801-806.
29. Faivre L, Gorlin RJ, Wirtz MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 2003; 40:34-36.
30. Burakgazi AZ, Ozbek Z, Rapuano CJ, Rhee DJ. Long-term complications of iris-claw phakic intraocular lens implantation in Weill-Marchesani syndrome. Cornea 2006; 25:361-363.
31. Chu BS. Weill-Marchesani syndrome and secondary glaucoma associated with ectopia lentis. Clin Exp Optom 2006; 89:95-99.
32. Razeghinejad MR, Safavian H. Central corneal thickness in patients with Weill-Marchesani syndrome. Am J Ophthalmol 2006; 142:507-508.
33. Mulvihill A, O'Keeffe M, Yap S, et al. Ocular axial length in homocystinuria patients with and without ocular changes: effects of early treatment and biochemical control. J AAPOS 2004; 8:254-258.
34. Ozdek S, Bahceci UA, Onol M, et al. Postoperative secondary glaucoma and anterior staphyloma in a patient with homocystinuria. J Pediatr Ophthalmol Strabismus 2005; 42:243-246.
35. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141:921-937.
36. Guo S, Gewirtz M, Thaker R, Reed M. Characterizing pseudoexfoliation syndrome through the use of ultrasound biomicroscopy. J Cataract Refract Surg 2006; 32:614-617.
37. Bahar I, Kaiserman I, Rootman D. Cionni endocapsular ring implantation in Marfan's syndrome. Br J Ophthalmol 2007; Epub ahead of print.
38. Konradsen T, Kugelberg M, Zetterstrom C. Visual outcomes and complications in surgery for ectopia lentis in children. J Cataract Refract Surg 2007; 33:819-824.
39. Condon GP, Masket S, Kranemann C, et al. Small-incision iris fixation of foldable intraocular lenses in the absence of capsule support. Ophthalmology 2007; 114:1311-1318.
40. Dureau P, De Laage de Meux P, Edelson C, Caputo G. Iris fixation of foldable intraocular lenses for ectopia lentis in children. J Cataract Refract Surg 2006; 32:1109-1114.